4dmedical Limited (ASX:4DX)

$1.35

right-arrow Created with Sketch. 0 (0%)
MCAP $397.5M
Last trade 09.07am 30/11/2021 20mins delayed

Latest Announcements

24/11/20214DX4dmedical Limited
24/11/20214DX4dmedical Limited
23/11/2021 Price SensitivePS4DX4dmedical Limited
09/11/20214DX4dmedical Limited
03/11/20214DX4dmedical Limited
03/11/20214DX4dmedical Limited
28/10/20214DX4dmedical Limited
148
MCap
28/10/20214DX4dmedical Limited
152
MCap

Company Overview

4DMedical Limited is an Australia-based medical technology company. The Company is focused on development of a non-invasive respiratory imaging solution using four-dimensional imaging. The Company's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. It enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

4DX in the news

4DMedical (4DX) begins the commercial rollout of its XV Lung Ventilation Analysis…
4DMedical (4DX) signs an agreement with I-MED Radiology Network to begin phase…
4DMedical (4DX) prepares sell one of its preclinical respiratory scanners to the…
Medical technology company 4DMedical (4DX) has released its quarterly update for the…

Search Previous Announcements